Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin

Brain Research

Volumn 1314, Issue , 2010, Pages 145-161

  Martin Fardon, Rémi ^a   Zorrilla, Eric P ^b   Ciccocioppo, Roberto ^c   Weiss, Friedbert ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Committee on the Neurobiology of Addictive Disorders ^*  (United States)

^c UNIVERSITY OF CAMERINO   (Italy)

Author keywords

Addiction; Allostasis; Anxiety; Corticotropin releasing factor; Nociceptin orphanin FQ; Orexin hypocretin; Reinstatement; Relapse; Stress

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; NOCICEPTIN; OREXIN;

ADDICTION; ALCOHOLISM; ANXIETY; AROUSAL; ARTICLE; BRAIN; DRUG DEPENDENCE; DRUG WITHDRAWAL; ENERGY METABOLISM; FEEDING; HUMAN; NONHUMAN; PRIORITY JOURNAL; STRESS;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; AROUSAL; BRAIN; COMORBIDITY; CORTICOTROPIN-RELEASING HORMONE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEURAL PATHWAYS; NEUROPEPTIDES; OPIOID PEPTIDES; STRESS, PSYCHOLOGICAL; SUBSTANCE-RELATED DISORDERS;

EID: 75449091356     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.12.027     Document Type: Article

References (166)

1. Ahmed S.H., and Koob G.F. Transition from moderate to excessive drug intake: change in hedonic set point. Science 282 (1998) 298-300
2. Ahmed S.H., and Koob G.F. Long-lasting increase in the set point for cocaine self-administration after escalation in rats. Psychopharmacology (Berl) 146 (1999) 303-312
3. Ahmed S.H., and Cador M. Dissociation of psychomotor sensitization from compulsive cocaine consumption. Neuropsychopharmacology 31 (2006) 563-571
4. Ahmed S.H., Kenny P.J., Koob G.F., and Markou A. Neurobiological evidence for hedonic allostasis associated with escalating cocaine use. Nat. Neurosci. 5 (2002) 625-626
5. Aouizerate B., Ho A., Schluger J.H., Perret G., Borg L., Le Moal M., Piazza P.V., and Kreek M.J. Glucocorticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: dose-response to dexamethasone suppression. Addict Biol. 11 (2006) 84-96
6. Aujla H., Martin-Fardon R., Sidhpura N., Zhao Y., and Weiss F. Nociceptin differentially regulates anxiety-like behaviours in ethanol-dependent vs. non-dependent rats. Soc. Neurosci. Abstr. 34 (2007) 63.3
7. Baldo B.A., Daniel R.A., Berridge C.W., and Kelley A.E. Overlapping distributions of orexin/hypocretin- and dopamine-β-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. J. Comp. Neurol. 464 (2003) 220-237
8. Basso A.M., Spina M., Rivier J., Vale W., and Koob G.F. Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats. Psychopharmacology (Berl) 145 (1999) 21-30
9. Behan D.P., De Souza E.B., Lowry P.J., Potter E., Sawchenko P., and Vale W.W. Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides. Front Neuroendocrinol. 16 (1995) 362-382
10. Bonci A., and Borgland S. Role of orexin/hypocretin and CRF in the formation of drug-dependent synaptic plasticity in the mesolimbic system. Neuropharmacology 56 Suppl. 1 (2009) 107-111
11. Borgland S.L., Taha S.A., Sarti F., Fields H.L., and Bonci A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49 (2006) 589-601
12. Borgland S.L., Chang S.J., Bowers M.S., Thompson J.L., Vittoz N., Floresco S.B., Chou J., Chen B.T., and Bonci A. Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J. Neurosci. 29 (2009) 11215-11225
13. Boutrel B. A neuropeptide-centric view of psychostimulant addiction. Br. J. Pharmacol. 154 (2008) 343-357
14. Boutrel B., Kenny P.J., Specio S.E., Martin-Fardon R., Markou A., Koob G.F., and de Lecea L. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 19168-19173
15. Braconi, S., Sidhpura, N., Aujla, H., Martin-Fardon, R., Weiss, F., Ciccocioppo, R., (In Press). Revisiting intragastric ethanol intubation as a dependence induction method for studies of ethanol reward and motivation in rats. Alcohol Clin. Exp. Res. 34 (3).
16. 1A-receptor agonist. Neuropsychopharmacology 29 (2004) 470-482
17. Brown S.A., Vik P.W., Patterson T.L., Grant I., and Schuckit M.A. Stress, vulnerability and adult alcohol relapse. J. Stud. Alcohol 56 (1995) 538-545
18. Brown Z.J., Tribe E., D'Souza N.A., and Erb S. Interaction between noradrenaline and corticotrophin-releasing factor in the reinstatement of cocaine seeking in the rat. Psychopharmacology (Berl) 203 (2009) 121-130
19. Chalmers D.T., Lovenberg T.W., and De Souza E.B. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J. Neurosci. 15 (1995) 6340-6350
20. Chen B.T., Bowers M.S., Martin M., Hopf F.W., Guillory A.M., Carelli R.M., Chou J.K., and Bonci A. Cocaine but not natural reward self-administration nor passive cocaine infusion produces persistent LTP in the VTA. Neuron 59 (2008) 288-297
21. Ciccocioppo R., Panocka I., Froldi R., Colombo G., Gessa G.L., and Massi M. Antidepressant-like effect of ethanol revealed in the forced swimming test in Sardinian alcohol-preferring rats. Psychopharmacology (Berl) 144 (1999) 151-157
22. Ciccocioppo R., Panocka I., Polidori C., Regoli D., and Massi M. Effect of nociceptin on alcohol intake in alcohol-preferring rats. Psychopharmacology (Berl) 141 (1999) 220-224
23. Ciccocioppo R., Angeletti S., Sanna P.P., Weiss F., and Massi M. Effect of nociceptin/orphanin FQ on the rewarding properties of morphine. Eur. J. Pharmacol. 404 (2000) 153-159
24. Ciccocioppo R., Martin-Fardon R., Weiss F., and Massi M. Nociceptin/orphanin FQ inhibits stress- and CRF-induced anorexia in rats. Neuroreport 12 (2001) 1145-1149
25. Ciccocioppo R., Economidou D., Fedeli A., and Massi M. The nociceptin/orphanin FQ/NOP receptor system as a target for treatment of alcohol abuse: a review of recent work in alcohol-preferring rats. Physiol. Behav. 79 (2003) 121-128
26. Ciccocioppo R., Fedeli A., Economidou D., Policani F., Weiss F., and Massi M. The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin/orphanin FQ. J. Neurosci. 23 (2003) 9445-9451
27. Ciccocioppo R., Economidou D., Fedeli A., Angeletti S., Weiss F., Heilig M., and Massi M. Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin/orphanin FQ in alcohol-preferring rats. Psychopharmacology (Berl) 172 (2004) 170-178
28. Ciccocioppo R., Economidou D., Cippitelli A., Cucculelli M., Ubaldi M., Soverchia L., Lourdusamy A., and Massi M. Genetically selected Marchigian Sardinian alcohol-preferring (msP) rats: an animal model to study the neurobiology of alcoholism. Addict Biol. 11 (2006) 339-355
29. Cleck J.N., and Blendy J.A. Making a bad thing worse: adverse effects of stress on drug addiction. J. Clin. Invest. 118 (2008) 454-461
30. Cruz M.T., Bajo M., Schweitzer P., and Roberto M. Ethanol dependence induces neuroadaptation of the nociceptin and CRF systems at the GABAergic synapses in the central amygdala. Program No. 552.17. 2009 Neuroscience Meeting Planner (2009), Society for Neuroscience, Chicago, IL 2009. Online
31. Cruz M.T., Schweitzer P., Siggins G.R., and Roberto M. Nociceptin opposes ethanol and CRF action on GABAergic synapses in the amygdala. Alcohol Clin. Exp. Res. Supp. 33 (2009) 149A
32. Cummings S., Elde R., Ells J., and Lindall A. Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study. J. Neurosci. 3 (1983) 1355-1368
33. Darland T., Heinricher M.M., and Grandy D.K. Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more. Trends Neurosci. 21 (1998) 215-221
34. Dayas C.V., McGranahan T.M., Martin-Fardon R., and Weiss F. Stimuli linked to ethanol availability activate hypothalamic CART and orexin neurons in a reinstatement model of relapse. Biol. Psychiatry 63 (2008) 152-157
35. Dave J.R., Eiden L.E., Karanian J.W., and Eskay R.L. Ethanol exposure decreases pituitary corticotropin-releasing factor binding, adenylate cyclase activity, proopiomelanocortin biosynthesis, and plasma beta-endorphin levels in the rat. Endocrinology 118 (1986) 280-286
36. Di Giannuario A., and Pieretti S. Nociceptin differentially affects morphine-induced dopamine release from the nucleus accumbens and nucleus caudate in rats. Peptides 21 (2000) 1125-1130
37. DiLeone R.J., Georgescu D., and Nestler E.J. Lateral hypothalamic neuropeptides in reward and drug addiction. Life Sci. 73 (2003) 759-768
38. Economidou D., Fedeli A., Martin-Fardon R., Weiss F., Massi M., and Ciccocioppo R. Effect of novel nociceptin/orphanin FQ-NOP receptor ligands on ethanol drinking in alcohol-preferring msP rats. Peptides 27 (2006) 3299-3306
39. Economidou D., Hansson A.C., Weiss F., Terasmaa A., Sommer W.H., Cippitelli A., Fedeli A., Martin-Fardon R., Massi M., Ciccocioppo R., and Heilig M. Dysregulation of nociceptin/orphanin FQ activity in the amygdala is linked to excessive alcohol drinking in the rat. Biol. Psychiatry 64 (2008) 211-218
40. Edwards C.M., Abusnana S., Sunter D., Murphy K.G., Ghatei M.A., and Bloom S.R. The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin. J. Endocrinol. 160 (1999) R7-R12
41. Erb S., and Brown Z.J. A role for corticotropin-releasing factor in the long-term expression of behavioral sensitization to cocaine. Behav. Brain Res. 172 (2006) 360-364
42. Erb S., Salmaso N., Rodaros D., and Stewart J. A role for the CRF-containing pathway from central nucleus of the amygdala to bed nucleus of the stria terminalis in the stress-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) 158 (2001) 360-365
43. Erb S., Funk D., and Le A.D. Prior, repeated exposure to cocaine potentiates locomotor responsivity to central injections of corticotropin-releasing factor (CRF) in rats. Psychopharmacology (Berl) 170 (2003) 383-389
44. Erb S., Funk D., and Le A.D. Cocaine pre-exposure enhances CRF-induced expression of c-fos mRNA in the central nucleus of the amygdala: an effect that parallels the effects of cocaine pre-exposure on CRF-induced locomotor activity. Neurosci. Lett. 383 (2005) 209-214
45. Erb S., Petrovic A., Yi D., and Kayyali H. Central injections of CRF reinstate cocaine seeking in rats after postinjection delays of up to 3 h: an influence of time and environmental context. Psychopharmacology (Berl) 187 (2006) 112-120
46. Fonareva I., Spangler E., Cannella N., Sabino V., Cottone P., Ciccocioppo R., Zorrilla E.P., and Ryabinin A.E. Increased perioculomotor urocortin 1 immunoreactivity in genetically selected alcohol preferring rats. Alcohol Clin. Exp. 33 (2009) 1956-1965
47. Francesconi W., Berton F., Repunte-Canonigo V., Hagihara K., Thurbon D., Lekic D., Specio S.E., Greenwell T.N., Chen S.A., Rice K.C., Richardson H.N., O'Dell L.E., Zorrilla E.P., Morales M., Koob G.F., and Sanna P.P. Protracted withdrawal from alcohol and drugs of abuse impairs long-term potentiation of intrinsic excitability in the juxtacapsular bed nucleus of the stria terminalis. J. Neurosci. 29 (2009) 5389-5401
48. 1 receptors. J. Neurophysiol. 97 (2007) 937-941
49. Funk D., Li Z., Shaham Y., and Le A.D. Effect of blockade of corticotropin-releasing factor receptors in the median raphe nucleus on stress-induced c-fos mRNA in the rat brain. Neuroscience 122 (2003) 1-4
50. Funk C.K., O'Dell L.E., Crawford E.F., and Koob G.F. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J. Neurosci. 26 (2006) 11324-11332
51. Funk C.K., Zorrilla E.P., Lee M.J., Rice K.C., and Koob G.F. Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol. Psychiatry 61 (2007) 78-86
52. Goeders N.E. Stress and cocaine addiction. J. Pharmacol. Exp. Ther. 301 (2002) 785-789
53. Gurkovskaya O., and Goeders N.E. Effects of CP-154,526 on responding during extinction from cocaine self-administration in rats. Eur. J. Pharmacol. 432 (2001) 53-56
54. Gutman D.A., Owens M.J., Skelton K.H., Thrivikraman K.V., and Nemeroff C.B. The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress. J. Pharmacol. Exp. Ther. 304 (2003) 874-880
55. Hahn J., Hopf F.W., and Bonci A. Chronic cocaine enhances corticotropin-releasing factor-dependent potentiation of excitatory transmission in ventral tegmental area dopamine neurons. J. Neurosci. 29 (2009) 6535-6544
56. Hamlin A.S., Clemens K.J., Choi E.A., and McNally G.P. Paraventricular thalamus mediates context-induced reinstatement (renewal) of extinguished reward seeking. Eur. J. Neurosci. 29 (2009) 802-812
57. Hansson A.C., Cippitelli A., Sommer W.H., Fedeli A., Bjork K., Soverchia L., Terasmaa A., Massi M., Heilig M., and Ciccocioppo R. Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 15236-15241
58. Hansson A.C., Cippitelli A., Sommer W.H., Ciccocioppo R., and Heilig M. Region-specific down-regulation of Crhr1 gene expression in alcohol-preferring msP rats following ad lib access to alcohol. Addict Biol. 12 (2007) 30-34
59. Harris G.C., Wimmer M., and Aston-Jones G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437 (2005) 556-559
60. Haynes A.C., Jackson B., Chapman H., Tadayyon M., Johns A., Porter R.A., and Arch J.R. A selective orexin-1 receptor antagonist reduces food consumption in male and female rats. Regul. Pept. 96 (2000) 45-51
61. Haynes A.C., Chapman H., Taylor C., Moore G.B., Cawthorne M.A., Tadayyon M., Clapham J.C., and Arch J.R. Anorectic, thermogenic and anti-obesity activity of a selective orexin-1 receptor antagonist in ob/ob mice. Regul. Pept. 104 (2002) 153-159
62. Hollander J.A., Lu Q., Cameron M.D., Kamenecka T.M., and Kenny P.J. Insular hypocretin transmission regulates nicotine reward. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 19480-19485
63. Huang J., Young B., Pletcher M.T., Heilig M., and Wahlestedt C. Association between the nociceptin receptor gene (OPRL1) single nucleotide polymorphisms and alcohol dependence. Addict Biol. 13 (2008) 88-94
64. Jaszberenyi M., Bujdoso E., Pataki I., and Telegdy G. Effects of orexins on the hypothalamic-pituitary-adrenal system. J. Neuroendocrinol. 12 (2000) 1174-1178
65. Kageyama K., and Suda T. Regulatory mechanisms underlying corticotropin-releasing factor gene expression in the hypothalamus. Endocr. J. 56 (2009) 335-344
66. Kelley A.E., and Berridge K.C. The neuroscience of natural rewards: relevance to addictive drugs. J. Neurosci. 22 (2002) 3306-3311
67. Kelley A.E., Baldo B.A., and Pratt W.E. A proposed hypothalamic-thalamic-striatal axis for the integration of energy balance, arousal, and food reward. J. Comp. Neurol. 493 (2005) 72-85
68. Knapp D.J., Overstreet D.H., Moy S.S., and Breese G.R. SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats. Alcohol 32 (2004) 101-111
69. Koob G.F. A role for brain stress systems in addiction. Neuron 59 (2008) 11-34
70. Koob G.F., and Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science 278 (1997) 52-58
71. Koob G.F., and Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24 (2001) 97-129
72. Koob G., and Kreek M.J. Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am. J. Psychiatry. 164 (2007) 1149-1159
73. Kotlinska J., Wichmann J., Legowska A., Rolka K., and Silberring J. Orphanin FQ/nociceptin but not Ro 65-6570 inhibits the expression of cocaine-induced conditioned place preference. Behav. Pharmacol. 13 (2002) 229-235
74. Kotlinska J., Rafalski P., Biala G., Dylag T., Rolka K., and Silberring J. Nociceptin inhibits acquisition of amphetamine-induced place preference and sensitization to stereotypy in rats. Eur. J. Pharmacol. 474 (2003) 233-239
75. Kuzmin A., Sandin J., Terenius L., and Ogren S.O. Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: effects of opioid receptor-like 1 receptor agonists and naloxone. J. Pharmacol. Exp. Ther. 304 (2003) 310-318
76. Lawrence A.J., Cowen M.S., Yang H.J., Chen F., and Oldfield B. The orexin system regulates alcohol-seeking in rats. Br. J. Pharmacol. 148 (2006) 752-759
77. Le A., and Shaham Y. Neurobiology of relapse to alcohol in rats. Pharmacol. Ther. 94 (2002) 137-156
78. Le A.D., Harding S., Juzytsch W., Fletcher P.J., and Shaham Y. The role of corticotropin-releasing factor in the median raphe nucleus in relapse to alcohol. J. Neurosci. 22 (2002) 7844-7849
79. Lee S., Schmidt D., Tilders F., Cole M., Smith A., and Rivier C. Prolonged exposure to intermittent alcohol vapors blunts hypothalamic responsiveness to immune and non-immune signals. Alcohol Clin. Exp. Res. 24 (2000) 110-122
80. Lindholm S., Ploj K., Franck J., and Nylander I. Nociceptin/orphanin FQ tissue concentration in the rat brain. Effects of repeated ethanol administration at various post-treatment intervals. Prog. Neuropsychopharmacol. Biol. Psychiatry 26 (2002) 303-306
81. Liu X., and Weiss F. Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J. Neurosci. 22 (2002) 7856-7861
82. Lovallo W.R., Dickensheets S.L., Myers D.A., Thomas T.L., and Nixon S.J. Blunted stress cortisol response in abstinent alcoholic and polysubstance-abusing men. Alcohol Clin. Exp. Res. 24 (2000) 651-658
83. Lovenberg T.W., Liaw C.W., Grigoriadis D.E., Clevenger W., Chalmers D.T., De Souza E.B., and Oltersdorf T. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 836-840
84. Lu L., Liu Z., Huang M., and Zhang Z. Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes. J. Neurochem. 84 (2003) 1378-1386
85. Lutfy K., Khaliq I., Carroll F.I., and Maidment N.T. Orphanin FQ/nociceptin blocks cocaine-induced behavioral sensitization in rats. Psychopharmacology (Berl) 164 (2002) 168-176
86. Lutfy K., Lam H., and Narayanan S. Alterations in the level of OFQ/N-IR in rat brain regions by cocaine. Neuropharmacology 55 (2008) 198-203
87. Mantsch J.R., Schlussman S.D., Ho A., and Kreek M.J. Effects of cocaine self-administration on plasma corticosterone and prolactin in rats. J. Pharmacol. Exp. Ther. 294 (2000) 239-247
88. Mantsch J.R., Ho A., Schlussman S.D., and Kreek M.J. Predictable individual differences in the initiation of cocaine self-administration by rats under extended-access conditions are dose-dependent. Psychopharmacology (Berl) 157 (2001) 31-39
89. Mantsch J.R., Cullinan W.E., Tang L.C., Baker D.A., Katz E.S., Hoks M.A., and Ziegler D.R. Daily cocaine self-administration under long-access conditions augments restraint-induced increases in plasma corticosterone and impairs glucocorticoid receptor-mediated negative feedback in rats. Brain Res. 1167 (2007) 101-111
90. Mantsch J.R., Baker D.A., Francis D.M., Katz E.S., Hoks M.A., and Serge J.P. Stressor- and corticotropin releasing factor-induced reinstatement and active stress-related behavioral responses are augmented following long-access cocaine self-administration by rats. Psychopharmacology (Berl) 195 (2008) 591-603
91. Marlatt G.A. Relapse prevention: introduction and overview of the model. In: Marlatt G.A., and Gordon J.R. (Eds). Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors (1985), Guilford, London 3-70
92. Martin-Fardon R., Ciccocioppo R., Massi M., and Weiss F. Nociceptin prevents stress-induced ethanol- but not cocaine-seeking behavior in rats. Neuroreport 11 (2000) 1939-1943
93. McKay J.R., Rutherford M.J., Alterman A.I., Cacciola J.S., and Kaplan M.R. An examination of the cocaine relapse process. Drug Alcohol Depend. 38 (1995) 35-43
94. Merlo-Pich E., Lorang M.T., Yeganeh M., Rodriguez de Fonseca F., Raber J., Koob G.F., and Weiss F. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J. Neurosci. 15 (1995) 5439-5447
95. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.L., Guillemot J.C., Ferrara P., Monsarrat B., Mazarguil H., Vassart G., Parmentier M., and Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377 (1995) 532-535
96. Meyer R.E. The disease called addiction: emerging evidence in a 200-year debate. Lancet 347 (1996) 162-166
97. Mogil J.S., Grisel J.E., Reinscheid R.K., Civelli O., Belknap J.K., and Grandy D.K. Orphanin FQ is a functional anti-opioid peptide. Neuroscience 75 (1996) 333-337
98. Mogil J.S., Grisel J.E., Zhangs G., Belknap J.K., and Grandy D.K. Functional antagonism of μ-, δ- and κ-opioid antinociception by orphanin FQ. Neurosci Lett. 214 (1996) 131-134
99. Morgan M.M., Grisel J.E., Robbins C.S., and Grandy D.K. Antinociception mediated by the periaqueductal gray is attenuated by orphanin FQ. Neuroreport 8 (1997) 3431-3434
100. Murphy N.P., and Maidment N.T. Orphanin FQ/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis. J. Neurochem. 73 (1999) 179-186
101. Murphy N.P., Lee Y., and Maidment N.T. Orphanin FQ/nociceptin blocks acquisition of morphine place preference. Brain Res. 832 (1999) 168-170
102. Neal Jr. C.R., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., and Watson Jr. S.J. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J. Comp. Neurol. 406 (1999) 503-547
103. Olive M.F., Koenig H.N., Nannini M.A., and Hodge C.W. Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacol. Biochem. Behav. 72 (2002) 213-220
104. 1 receptors. Pharmacol. Biochem. Behav. 77 (2004) 405-413
105. Paneda C., Winsky-Sommerer R., Boutrel B., and de Lecea L. The corticotropin-releasing factor-hypocretin connection: implications in stress response and addiction. Drug News Perspect 18 (2005) 250-255
106. Parsons M.P., Li S., and Kirouac G.J. The paraventricular nucleus of the thalamus as an interface between the orexin and CART peptides and the shell of the nucleus accumbens. Synapse 59 (2006) 480-490
107. Perry S.J., Junger S., Kohout T.A., Hoare S.R., Struthers R.S., Grigoriadis D.E., and Maki R.A. Distinct conformations of the corticotropin releasing factor type 1 receptor adopted following agonist and antagonist binding are differentially regulated. J. Biol. Chem. 280 (2005) 11560-11568
108. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., and Kilduff T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18 (1998) 9996-10015
109. Piazza P.V., and Le Moal M. The role of stress in drug self-administration. Trends Pharmacol. Sci. 19 (1998) 67-74
110. Pollandt S., Liu J., Orozco-Cabal L., Grigoriadis D.E., Vale W.W., Gallagher J.P., and Shinnick-Gallagher P. Cocaine withdrawal enhances long-term potentiation induced by corticotropin-releasing factor at central amygdala glutamatergic synapses via CRF, NMDA receptors and PKA. Eur. J. Neurosci. 24 (2006) 1733-1743
111. 1 receptor antagonist, on behavioral responses to cocaine in rats. Neuropeptides 39 (2005) 525-533
112. Rasmussen D.D., Boldt B.M., Bryant C.A., Mitton D.R., Larsen S.A., and Wilkinson C.W. Chronic daily ethanol and withdrawal: 1. Long-term changes in the hypothalamo-pituitary-adrenal axis. Alcohol Clin. Exp. Res. 24 (2000) 1836-1849
113. Rassnick S., Heinrichs S.C., Britton K.T., and Koob G.F. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res. 605 (1993) 25-32
114. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma Jr. F.J., and Civelli O. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 270 (1995) 792-794
115. Reyes T.M., Walker J.R., DeCino C., Hogenesch J.B., and Sawchenko P.E. Categorically distinct acute stressors elicit dissimilar transcriptional profiles in the paraventricular nucleus of the hypothalamus. J. Neurosci. 23 (2003) 5607-5616
116. Reyes B.A., Fox K., Valentino R.J., and Van Bockstaele E.J. Agonist-induced internalization of corticotropin-releasing factor receptors in noradrenergic neurons of the rat locus coeruleus. Eur. J. Neurosci. 23 (2006) 2991-2998
117. Reyes B.A., Valentino R.J., and Van Bockstaele E.J. Stress-induced intracellular trafficking of corticotropin-releasing factor receptors in rat locus coeruleus neurons. Endocrinology 149 (2008) 122-130
118. Richards J.K., Simms J.A., Steensland P., Taha S.A., Borgland S.L., Bonci A., and Bartlett S.E. Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology (Berl) 199 (2008) 109-117
119. Richardson H.N., Lee S.Y., O'Dell L.E., Koob G.F., and Rivier C.L. Alcohol self-administration acutely stimulates the hypothalamic-pituitary-adrenal axis, but alcohol dependence leads to a dampened neuroendocrine state. Eur. J. Neurosci. 28 (2008) 1641-1653
120. Richter R.M., and Weiss F. In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats. Synapse 32 (1999) 254-261
121. Richter R.M., Zorrilla E.P., Basso A.M., Koob G.F., and Weiss F. Altered amygdalar CRF release and increased anxiety-like behavior in Sardinian alcohol-preferring rats: a microdialysis and behavioral study. Alcohol Clin. Exp. Res. 24 (2000) 1765-1772
122. Roberto M., and Siggins G.R. Nociceptin/orphanin FQ presynaptically decreases GABAergic transmission and blocks the ethanol-induced increase of GABA release in central amygdala. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 9715-9720
123. Rodaros D., Caruana D.A., Amir S., and Stewart J. Corticotropin-releasing factor projections from limbic forebrain and paraventricular nucleus of the hypothalamus to the region of the ventral tegmental area. Neuroscience 150 (2007) 8-13
124. Rodi D., Zucchini S., Simonato M., Cifani C., Massi M., and Polidori C. Functional antagonism between nociceptin/orphanin FQ (N/OFQ) and corticotropin-releasing factor (CRF) in the rat brain: evidence for involvement of the bed nucleus of the stria terminalis. Psychopharmacology (Berl) 196 (2008) 523-531
125. Rodriguez de Fonseca F., Carrera M.R.A., Navarro M., Koob G.F., and Weiss F. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 276 (1997) 2050-2054
126. Rosin A., Kitchen I., and Georgieva J. Effects of single and dual administration of cocaine and ethanol on opioid and ORL1 receptor expression in rat CNS: an autoradiographic study. Brain Res. 978 (2003) 1-13
127. 1 antagonist sensitive drinking in Sardinian alcohol-preferring rats. Psychopharmacology (Berl) 189 (2006) 175-186
128. Sakoori K., and Murphy N.P. Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice. Psychopharmacology (Berl) 172 (2004) 129-136
129. Sakoori K., and Murphy N.P. Endogenous nociceptin (orphanin FQ) suppresses basal hedonic state and acute reward responses to methamphetamine and ethanol, but facilitates chronic responses. Neuropsychopharmacology 33 (2008) 877-891
130. Sakoori K., and Murphy N.P. Enhanced nicotine sensitivity in nociceptin/orphanin FQ receptor knockout mice. Neuropharmacology 56 (2009) 896-904
131. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., and Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92 (1998) 573-585
132. Sarnyai Z. Neurobiology of stress and cocaine addiction: studies on corticotropin-releasing factor in rats, monkeys, and humans. Ann. N.Y. Acad. Sci. 851 (1998) 371-387
133. Sarnyai Z., Hohn J., Szabo G., and Penke B. Critical role of endogenous corticotropin-releasing factor (CRF) in the mediation of the behavioral action of cocaine in rats. Life Sci. 51 (1992) 2019-2024
134. Sarnyai Z., Biro E., Gardi J., Vecsernyes M., Julesz J., and Telegdy G. Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats. Brain Res. 675 (1995) 89-97
135. Sarnyai Z., Shaham Y., and Heinrichs S.C. The role of corticotropin-releasing factor in drug addiction. Pharmacol Rev. 53 (2001) 209-243
136. Schulkin J., Gold P.W., and McEwen B.S. Induction of corticotropin-releasing hormone gene expression by glucocorticoids: implication for understanding the states of fear and anxiety and allostatic load. Psychoneuroendocrinology 23 (1998) 219-243
137. Shaham Y., Erb S., and Stewart J. Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res. Brain Res. Rev. 33 (2000) 13-33
138. Shaham Y., Shalev U., Lu L., De Wit H., and Stewart J. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl) 168 (2003) 3-20
139. Shalev U., Morales M., Hope B., Yap J., and Shaham Y. Time-dependent changes in extinction behavior and stress-induced reinstatement of drug seeking following withdrawal from heroin in rats. Psychopharmacology (Berl) 156 (2001) 98-107
140. Sinha R. How does stress increase risk of drug abuse and relapse?. Psychopharmacology (Berl) 158 (2001) 343-359
141. Smith R.J., Tahsili-Fahadan P., and Aston-Jones G. Orexin/hypocretin is necessary for context-driven cocaine-seeking. Neuropharmacology 58 (2010) 179-184
142. Sommer W.H., Rimondini R., Hansson A.C., Hipskind P.A., Gehlert D.R., Barr C.S., and Heilig M.A. Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala crhr1 expression following a history of dependence. Biol. Psychiatry 63 (2008) 139-145
143. 1 receptor antagonists attenuate escalated cocaine self-administration in rats. Psychopharmacology (Berl) 196 (2008) 473-482
144. Stewart J. Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking. J. Psychiatry. Neurosci. 25 (2000) 125-136
145. Stopponi S., Braconi S., Economidou D., Cippitelli A., Ubaldi M., Clementi S., Massi M., and Ciccocioppo R. Activation of central nociceptin/orphanin FQ receptors reduced alcohiol drinking and alcohol withdrawal associated symptoms. Behav. Pharmacol. 20 (2009) S32
146. Sutcliffe J.G., and de Lecea L. The hypocretins: setting the arousal threshold. Nat. Rev. Neurosci. 3 (2002) 339-349
147. Taheri S., Zeitzer J.M., and Mignot E. The role of hypocretins (orexins) in sleep regulation and narcolepsy. Annu. Rev. Neurosci. 25 (2002) 283-313
148. Timpl P., Spanagel R., Sillaber I., Kresse A., Reul J.M., Stalla G.K., Blanquet V., Steckler T., Holsboer F., and Wurst W. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat. Genet. 19 (1998) 162-166
149. Ungless M.A., Singh V., Crowder T.L., Yaka R., Ron D., and Bonci A. Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons. Neuron 39 (2003) 401-407
150. Valdez G.R., Roberts A.J., Chan K., Davis H., Brennan M., Zorrilla E.P., and Koob G.F. Increased ethanol self-administration and anxiety-like
151. Vale W., Spiess J., Rivier C., and Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 213 (1981) 1394-1397
152. Wallace B.C. Psychological and environmental determinants of relapse in crack cocaine smokers. J. Subst. Abuse Treat. 6 (1989) 95-106
153. Wand G.S., and Dobs A.S. Alterations in the hypothalamic-pituitary-adrenal axis in actively drinking alcoholics. J. Clin. Endocrinol. Metab. 72 (1991) 1290-1295
154. Wang B., Shaham Y., Zitzman D., Azari S., Wise R.A., and You Z.B. Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: a role in stress-induced relapse to drug seeking. J. Neurosci. 25 (2005) 5389-5496
155. Wang B., You Z.B., Rice K.C., and Wise R.A. Stress-induced relapse to cocaine seeking: roles for the CRF(2) receptor and CRF-binding protein in the ventral tegmental area of the rat. Psychopharmacology (Berl) 193 (2007) 283-294
156. Wang B., You Z.B., and Wise R.A. Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: independence from the local corticotropin-releasing factor network. Biol. Psychiatry 65 (2009) 857-862
157. Wee S., Specio S.E., and Koob G.F. Effects of dose and session duration on cocaine self-administration in rats. J. Pharmacol. Exp. Ther. 320 (2007) 1134-1143
158. Weiss F., Ciccocioppo R., Parsons Ls.H., Katner S., Liu X., Zorrilla E.P., Valdez G.R., Ben-Shahar O., Angeletti S., and Richter R.R. Compulsive drug-seeking behavior and relapse: neuroadaptation, stress, and conditioning factors. Ann. N. Y. Acad. Sci. 937 (2001) 1-26
159. Willie J.T., Chemelli R.M., Sinton C.M., and Yanagisawa M. To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu. Rev. Neurosci. 24 (2001) 429-458
160. Winsky-Sommerer R., Yamanaka A., Diano S., Borok E., Roberts A.J., Sakurai T., Kilduff T.S., Horvath T.L., and de Lecea L. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J. Neurosci. 24 (2004) 11439-11448
161. Xie X., Wisor J.P., Hara J., Crowder T.L., LeWinter R., Khroyan T.V., Yamanaka A., Diano S., Horvath T.L., Sakurai T., Toll L., and Kilduff T.S. Hypocretin/orexin and nociceptin/orphanin FQ coordinately regulate analgesia in a mouse model of stress-induced analgesia. J. Clin. Invest. 118 (2008) 2471-2481
162. Xuei X., Flury-Wetherill L., Almasy L., Bierut L., Tischfield J., Schuckit M., Nurnberger Jr. J.I., Foroud T., and Edenberg H.J. Association analysis of genes encoding the nociceptin receptor (OPRL1) and its endogenous ligand (PNOC) with alcohol or illicit drug dependence. Addict Biol. 13 (2008) 80-87
163. Zhao R.J., Woo R.S., Jeong M.S., Shin B.S., Kim D.G., and Kim K.W. Orphanin FQ/nociceptin blocks methamphetamine place preference in rats. Neuroreport 14 (2003) 2383-2385
164. 1 antagonists for anxiety. Expert Opin. Investig. Drugs 13 (2004) 799-828
165. Zorrilla E.P., and Koob G.F. The roles of urocorins 1, 2 and 3 in the brain. In: Steckler T., Kalin N.H., and Reul J.M.H.M. (Eds). Handbook of Stress and the Brain (series title: Techniques in the Behavioral and Neural Sciences, vol. 15) (2005), Elsevier Science, New York 179-203
166. Zorrilla E.P., Valdez G.R., and Weiss F. Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology (Berl) 158 (2001) 374-381